首页> 美国卫生研究院文献>Kidney International Reports >Acute Peritoneal Dialysis With Percutaneous Catheter Insertion for COVID-19–Associated Acute Kidney Injury in Intensive Care: Experience From a UK Tertiary Center
【2h】

Acute Peritoneal Dialysis With Percutaneous Catheter Insertion for COVID-19–Associated Acute Kidney Injury in Intensive Care: Experience From a UK Tertiary Center

机译:急性腹膜透析伴有经皮导管插入用于Covid-19相关的急性肾损伤重症监护:来自英国第三级的经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

During the coronavirus disease 2019 (COVID-19) pandemic in 2020, high rates of acute kidney injury (AKI) in critically unwell patients are being reported, leading to an increased demand for renal replacement therapy (RRT). Providing RRT for this large number of patients is proving challenging, and so alternatives to continuous renal replacement therapies (CRRT) in the intensive care unit (ICU) are needed. Peritoneal dialysis (PD) can be initiated immediately after percutaneous insertion of the catheter, but there are concerns about impact on ventilation and RRT efficacy. We sought to describe our recent experience with percutaneous catheter insertion and peritoneal dialysis in patients in the ICU with COVID-19 infection.
机译:在2020年的冠状病毒疾病2019年(Covid-19)大流行期间,报告了严重患者患者的高急性肾损伤(AKI),导致肾替代治疗的需求增加(RRT)。为此大量患者提供RRT正在证明挑战,因此需要在重症监护单元(ICU)中连续肾脏替代疗法(CRRT)的替代方案。腹膜透析(PD)可以在经皮在经皮插入导管后立即引发,但是涉及对通气和RRT功效的影响。我们试图用Covid-19感染的ICU患者经皮导管插入和腹膜透析的近期经验描述了我们最近的经验。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号